In Oct. 2024, the vitamin market remained stable overall, and different varieties showed divergent trends. The trade market for vitamin A and vitamin E was actively shipping, and prices declined from high levels. The price center of gravity of vitamin C moved upwards slightly due to major manufacturers raising quotes.
The SAMR released Draft for Comments on Dosage Forms and Technical Requirements for Health Food Record Products (2024 Edition) and Draft for Comments on Excipients and Their Usage Regulations for Health Food Record Products (2024 Edition).
Two vitamin listed companies Zhejiang Garden Biopharmaceutical Co., Ltd. and Zhejiang Medicine Co., Ltd. release results for Q3 2024.
Project progress of many company
- Xinjiang Yilihong's two agricultural and sideline product deep processing projects;
- Tianxin Pharmaceutical's folic acid expansion and renovation project;
- Kexing Biochemical's food and feed additives and health food technology improvement project;
- Minfeng Chemical's chromium-titanium new material green intelligent manufacturing environmental relocation project;
The USD/RMB exchange rate in this Report is USD1.00=CNY7.0709 on 8 Oct., 2024, sourced from the People's Bank of China. All the prices mentioned in this Report will include the VAT, unless otherwise specified.
- SAMR released drafts on record of health food products for public comments
- Progress of two listed companies's health food business
- Update of new NMN production capacity projects
- Situation of Shengda Bio-pharm's non-public issuance of A-shares project
- Chundi Biotechnology commissions the development of calcitriol API externally
- Xinjiang Yilihong's two agricultural and sideline product deep processing projects
- Tianxin Pharmaceutical's folic acid expansion and renovation project completed
- Kexing Biochemical's food and feed additives and health food technology improvement project
- Imports and exports of selected vitamins in China, Sept. 2024
- China's vitamin exports up 11.85% YOY in Q1–Q3 2024
- Ex-works prices of selected vitamins in China, Oct. 2024
- Vitamin market remained stable in Oct. 2024
- Inner Mongolia Kingdomway obtained feed additive production license for inositol
- Pharscin Pharmaceutical entrusted to produce vitamin D drops
- Second-time EIA publication of Rionlon Pharma's vitamin K2 project
- Luwei Pharma's vitamin C selected for "Shandong manufacturing Qilu boutique"
- Sine WanXiang Pharma's alfacalcidol API marketing application approved
- Progress of Ningxia Tianxin's 499,600 t/a fine chemical products project
- Tianli Pharma Vitamin Branch obtained feed additive production license for vitamin C
- Inner Mongolia Kingdomway's project of phase II and III are under construction
- Minfeng Chemical's relocation project aims to increase VK3 capacity
- Two vitamin listed companies release results for Q3 2024

